A phase 1 multi-center, dose escalation and pharmacokinetic study of L-NDDP (Aroplatin) in patients with advanced solid malignancies or B-cell lymphoma

Trial Profile

A phase 1 multi-center, dose escalation and pharmacokinetic study of L-NDDP (Aroplatin) in patients with advanced solid malignancies or B-cell lymphoma

Completed
Phase of Trial: Phase I

Latest Information Update: 07 Dec 2016

At a glance

  • Drugs L NDDP (Primary)
  • Indications B cell lymphoma; Solid tumours
  • Focus Adverse reactions; Pharmacokinetics
  • Sponsors Agenus
  • Most Recent Events

    • 24 Oct 2008 Status changed from recruiting to completed, based on information from ClinicalTrials.gov.
    • 27 Jul 2006 Status change
    • 30 Mar 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top